Key points are not available for this paper at this time.
Changes in ctDNA fraction and PSA levels between baseline and 4 weeks on-treatment in relation to the durability of response
Tolmeijer et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: